Related Experiment Video

Updated: Jul 18, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.2K

TMEM16A ion channel: A novel target for cancer treatment

Shuting Li1, Zhichen Wang1, Ruili Geng1

  • 1School of Life Sciences, Hebei University, Baoding 071002, Hebei, China.

Life Sciences
|August 23, 2023
PubMed

Insights

The calcium-activated chloride channel TMEM16A is implicated in cancer development and progression. Inhibiting TMEM16A shows promise as a therapeutic strategy for various cancers, highlighting its potential as a drug target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Channelopathies

Background:

  • High cancer morbidity and mortality necessitate novel therapeutic targets.
  • The calcium-activated chloride channel TMEM16A (also known as anoctamin-1) plays roles in various physiological processes.
  • Abnormal TMEM16A expression is linked to tumorigenesis, metastasis, and poor prognosis in multiple cancer types.

Purpose of the Study:

  • To review the association between TMEM16A and various cancers.
  • To analyze the molecular mechanisms driving TMEM16A overexpression in cancer.
  • To summarize TMEM16A's role in cancer signaling pathways and explore therapeutic strategies.

Main Methods:

  • Literature review of studies investigating TMEM16A in cancer.
  • Analysis of molecular mechanisms underlying TMEM16A dysregulation.
  • Summary of signal transduction pathways involving TMEM16A in cancer development.
  • Review of TMEM16A inhibitors and their anticancer mechanisms.

Main Results:

  • TMEM16A is abnormally expressed in several cancers, correlating with tumorigenesis and metastasis.
  • Knockdown or inhibition of TMEM16A significantly impedes cancer cell proliferation and development.
  • TMEM16A is identified as a potential biomarker and therapeutic target for specific cancers.

Conclusions:

  • TMEM16A represents a promising therapeutic target for cancer treatment.
  • Understanding TMEM16A's role in cancer offers new avenues for pharmacological intervention.
  • Further research into TMEM16A inhibitors could lead to effective cancer therapies.
Keywords:
CancerDrug targetExpression mechanismRegulation mechanismTMEM16A

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

645

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K